ArticlePloS one2019

Cost-effectiveness analysis of aspirin for primary prevention of cardiovascular events among patients with type 2 diabetes in China.

Minghuan Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.